Silk Fibroin Materials: Biomedical Applications and Perspectives

Bioengineering (Basel). 2024 Feb 9;11(2):167. doi: 10.3390/bioengineering11020167.

Abstract

The golden rule in tissue engineering is the creation of a synthetic device that simulates the native tissue, thus leading to the proper restoration of its anatomical and functional integrity, avoiding the limitations related to approaches based on autografts and allografts. The emergence of synthetic biocompatible materials has led to the production of innovative scaffolds that, if combined with cells and/or bioactive molecules, can improve tissue regeneration. In the last decade, silk fibroin (SF) has gained attention as a promising biomaterial in regenerative medicine due to its enhanced bio/cytocompatibility, chemical stability, and mechanical properties. Moreover, the possibility to produce advanced medical tools such as films, fibers, hydrogels, 3D porous scaffolds, non-woven scaffolds, particles or composite materials from a raw aqueous solution emphasizes the versatility of SF. Such devices are capable of meeting the most diverse tissue needs; hence, they represent an innovative clinical solution for the treatment of bone/cartilage, the cardiovascular system, neural, skin, and pancreatic tissue regeneration, as well as for many other biomedical applications. The present narrative review encompasses topics such as (i) the most interesting features of SF-based biomaterials, bare SF's biological nature and structural features, and comprehending the related chemo-physical properties and techniques used to produce the desired formulations of SF; (ii) the different applications of SF-based biomaterials and their related composite structures, discussing their biocompatibility and effectiveness in the medical field. Particularly, applications in regenerative medicine are also analyzed herein to highlight the different therapeutic strategies applied to various body sectors.

Keywords: 3D scaffolds; biomaterials; biomedicine; bone regeneration; fibroin; films; hydrogels; regenerative medicine; silk; tissue engineering.

Publication types

  • Review

Grants and funding

The research presented herein was carried out under the PRIN project: progetti di ricerca di rilevante interesse nazionale—Bando 2022 PNRR No. P2022NC9NT CUP: D53D23016540001. All the authors acknowledge the support they received from the National Recovery and Resilience Plan (NRRP), Mission 04 Component 2 Investment 1.5—NextGenerationEU, Call for tender n. 3277 dated 30 December 2021, Award Number: 0001052 dated 23 June 2022 and PNRR-M4C2-I1.5, Project ECS00000033, CUP D93C22000460001. G.T. and P.D. gratefully acknowledge the support they received from the European Union’s Horizon Europe research and innovation program under the Pathfinder Challenge grant agreement No. 101115545—IV-Lab.